Siblings With Ischemic Stroke Study (SWISS)
The purpose of this study is to find the genes that increase the risk of developing an ischemic stroke using DNA samples collected from concordant (stroke-affected) sibling pairs.
|Study Design:||Observational Model: Family-Based
Time Perspective: Prospective
|Official Title:||Siblings With Ischemic Stroke Study|
|Study Start Date:||December 2000|
|Study Completion Date:||June 2011|
|Primary Completion Date:||June 2009 (Final data collection date for primary outcome measure)|
Stroke is the third leading cause of death in the United States and a leading cause of acquired disability in adults. Each year, about 700,000 people experience stroke in the country. Ischemic stroke, which constitutes about 80 percent of all strokes, is a complex genetic disorder--the result of interactions between multiple genes and multiple environmental exposures. Genes affecting cholesterol, blood pressure, clotting, and other factors may increase the risk of ischemic stroke.
In this clinical study, investigators are studying groups of siblings in which at least two of the siblings have had an ischemic stroke. The goal of this multi-center study is to find the genes that increase the risk of developing an ischemic stroke.
To accomplish the aims of the study, researchers are using DNA samples collected from concordant (stroke-affected) sibling pairs to determine if there are regions in the human genome associated with ischemic stroke or that may harbor stroke susceptibility genes.
Two teaspoons of blood will be collected from each participant and submitted for genetic analysis. Understanding the genetic predisposition to stroke could have major benefits for public health.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00108940
Show 32 Study Locations
|Principal Investigator:||James F. Meschia, M.D.||Mayo Clinic College of Medicine Jacksonville|